GlassScriptPhysician profile
Beth A Bartholomew
NPI 1649230103
$2,061.40
in general payments reported to CMS, 2019-2025
21 companies · $92.77 in 2025
The $92.77 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $218 · 2021: $293 · 2022: $222 · 2023: $301 · 2024: $338 · 2025: $92.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $403.23 | 2022-2025 | Barostim Neo System |
| Glaxosmithkline, LLC. | $325.30 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $294.32 | 2019-2024 | |
| Boston Scientific Corporation | $237.94 | 2019-2023 | Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $121.24 | 2019-2024 | Xarelto |
| Amgen INC. | $108.98 | 2019-2022 | |
| Abbott Laboratories | $104.66 | 2021-2024 | Amplatzer Amulet |
| Merck Sharp & Dohme LLC | $102.17 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.01 | 2019-2024 | Lifevest |
| Pfizer INC. | $55.03 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.69 | 2019-2020 | |
| Bracco Diagnostics INC. | $29.93 | 2025 | |
| Bardy Diagnostics, INC. | $25.50 | 2020-2021 | |
| Abiomed | $19.46 | 2025 | |
| Philips North America LLC | $19.27 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $18.30 | 2021 | |
| Medtronic, INC. | $18.12 | 2024 | Linq II |
| Novo Nordisk INC | $17.99 | 2022 | |
| Kestra Medical Technology Services, INC. | $16.65 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $14.49 | 2021 | |
| Daiichi Sankyo INC. | $14.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Bartholomew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.